Tuberculosis
Showing NaN - NaN of 33
HIV, Tuberculosis, Diabetes Trial in Johannesburg (Minimum package of interventions to improve ART adherence)
Completed
- HIV
- +3 more
- Minimum package of interventions to improve ART adherence
-
Johannesburg, South AfricaJohannesburg Site
Jul 29, 2019
Tuberculosis Trial in South Africa, Tanzania, Uganda (PA-824, bedaquiline, moxifloxacin)
HIV-1 Infection, Tuberculosis Trial in Worldwide (Depot medroxyprogesterone acetate)
Completed
- HIV-1 Infection
- Tuberculosis
- Depot medroxyprogesterone acetate
-
Gaborone, Botswana
- +4 more
Jun 13, 2019
Influenza, HIV, Tuberculosis Trial in Johannesburg (Trivalent Inactivated Influenza Vaccine)
Completed
- Influenza
- +2 more
- Trivalent Inactivated Influenza Vaccine
-
Johannesburg, Gauteng, South AfricaRespiratory and Meningeal Pathogens research unit
Sep 3, 2018
Tuberculosis Trial in Cape Town, Johannesburg (VPM1002, BCG, VPM1002(Hyg+))
Completed
- Tuberculosis
- VPM1002
- +2 more
-
Cape Town, South Africa
- +3 more
Apr 17, 2018
Tuberculosis Trial in Johannesburg, Cape Town, Worcester (AERAS-404, Placebo)
Completed
- Tuberculosis
- AERAS-404
- Placebo
-
Johannesburg, Guateng, South Africa
- +3 more
Apr 6, 2018
HIV Infection, Tuberculosis Trial in Worldwide (Standard-dose Lopinavir/Ritonavir, Double-dose Lopinavir/Ritonavir, Raltegravir)
Terminated
- HIV Infection
- Tuberculosis
- Standard-dose Lopinavir/Ritonavir
- +8 more
-
Porto Alegre, RS, Brazil
- +8 more
Feb 7, 2018
Diagnostics in HIV-Infected Individuals
Completed
- HIV Infections
- Tuberculosis
- Standardized diagnostic evaluation
-
Gaborone, Botswana
- +12 more
Mar 17, 2015